跳转至内容
Merck

51371

Sigma-Aldrich

异戊酰-L -肉碱

≥94.0% (HPLC)

别名:

(2 R )-3-羧基- N N N -三甲基-2-(3-甲基-1-氧代丁氧基)-1-丙胺 内盐, L-肉碱异戊酸酯, iC5-肉碱

登录查看公司和协议定价


About This Item

经验公式(希尔记法):
C12H23NO4
CAS号:
分子量:
245.32
Beilstein:
5946880
分類程式碼代碼:
12352209
PubChem物質ID:
NACRES:
NA.26

产品名称

异戊酰-L -肉碱, ≥94.0% (HPLC)

品質等級

化驗

≥94.0% (HPLC)

形狀

powder or crystals

光學活性

[α]/D -23±2°, c = 1 in H2O

雜質

≤10% water

顏色

white to off-white

儲存溫度

2-8°C

SMILES 字串

C[N+](C)(C)C[C@H](OC(CC(C)C)=O)CC([O-])=O

InChI

1S/C12H23NO4/c1-9(2)6-12(16)17-10(7-11(14)15)8-13(3,4)5/h9-10H,6-8H2,1-5H3/t10-/m1/s1

InChI 密鑰

IGQBPDJNUXPEMT-SNVBAGLBSA-N

正在寻找类似产品? 访问 产品对比指南

應用


  • L: -carnitine fumarate and isovaleryl-L: -carnitine fumarate accelerate the recovery of bone volume/total volume ratio after experimentally induced osteoporosis in pregnant mice.: This study explores the therapeutic potential of Isovaleryl-L-carnitine in improving bone volume in conditions of osteoporosis, indicating its significant impact on bone health (Patano et al., 2008).

  • L-carnitine and isovaleryl L-carnitine fumarate positively affect human osteoblast proliferation and differentiation in vitro.: This article discusses the positive effects of Isovaleryl-L-carnitine on human osteoblast cells, contributing to bone formation and health, showcasing its applications in regenerative medicine and bone repair (Colucci et al., 2005).

生化/生理作用

异戊酰肉碱是异戊酸血症的表型异常,由异戊酸的积累引起,对中枢神经系统有毒。异戊酸血症是由线粒体酶异戊酰辅酶A脱氢酶缺乏引起的亮氨酸代谢的常染色体隐性先天性错缺陷,导致异戊酰辅酶A衍生物的积累。它是人类中第一个公认的有机酸血症,可导致显著的发病率和死亡率。早期诊断和蛋白限制饮食以及补充肉毒碱和甘氨酸的治疗可有效促进严重受影响个体的正常发育。通过甘氨酸-N-酰化酶的另一种途径允许通过产生可被排泄的异戊酰-甘氨酸进行解毒治疗。因此,异戊酰肉碱和异戊酰甘氨酸分别是血浆和尿液中该疾病的标志,并且无论患者′的代谢状况如何,其水平均升高。

儲存類別代碼

11 - Combustible Solids

水污染物質分類(WGK)

WGK 3

閃點(°F)

Not applicable

閃點(°C)

Not applicable


从最新的版本中选择一种:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Jerry Vockley et al.
American journal of medical genetics. Part C, Seminars in medical genetics, 142C(2), 95-103 (2006-04-08)
Isovaleric acidemia (IVA) is an autosomal recessive inborn error of leucine metabolism caused by a deficiency of the mitochondrial enzyme isovaleryl-CoA dehydrogenase (IVD) resulting in the accumulation of derivatives of isovaleryl-CoA. It was the first organic acidemia recognized in humans
Organic acid profile of isovaleric acidemia: a comprehensive metabolomics approach.
Dercksen, M., et al.
Metabolomics, 9, 765-777 (2013)
F Salamino et al.
Pediatric research, 36(2), 182-186 (1994-08-01)
When a 12-y-old girl suffering from isovaleric acidemia was treated with L-carnitine, there was a considerable increase in her blood and urine concentration of isovalerylcarnitine. When later the patient received an infusion of glycine in place of carnitine, isovalerylcarnitine reverted
M H Fries et al.
The Journal of pediatrics, 129(3), 449-452 (1996-09-01)
To assess the effectiveness of glycine and carnitine therapy on isovaleryl conjugate excretion in isovaleric acidemia (IVA). Urinary isovalerylglycine (IVG) and isovalerylcarnitine (IVC) were measured from 12-hour urine specimens collected overnight from an 8-year-old patient with IVA (who had no
David Meierhofer
PloS one, 14(8), e0221342-e0221342 (2019-08-16)
Acylcarnitines are fatty acyl esters of L-carnitine and facilitate the entry of long-chain fatty acids into mitochondria via the carnitine shuttle, where they are metabolized via ß-oxidation. Alterations of acylcarnitine species can be diagnostic for fatty acid oxidation disorders and

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门